In each of these, immunohistochemistry for SMARCB1 is a reliable surrogate for underlying SMARCB1 inactivation, since tumor cell nuclei frequently show loss of expression alongside retained expression in non-neoplastic cells. This evidence concerns the gene SMARCB1 and neoplasm.